References
- Angst J, Preisig M. Outcome of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985. Schweiz Arch Neurol Psychiatr 1995; 146: 17–23
- Kessing LV, Andersen PK. Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder?. J Neurol Neurosurg Psychiatry 2004; 75: 1662–1666
- Egeland J, Lund A, Landro NI, Rund BR, Sundet K, Asbjornsen A, et al. Cortisol level predicts executive and memory function in depression, symptom level predicts psychomotor speed. Acta Psychiatr Scand 2005; 112: 434–441
- Manji HK, Moore GJ, Chen G. Clinical and preclinical evidence for the neurotrophic effect of mood stabilizers: implications for the pathophsyiology and treatment of manic-depressive illness. Biol Psychiatry 2000; 48: 740–754
- Manji HK, Moore GJ, Chen G. Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?. Biol Psychiatry 1999; 46: 929–940
- Chuang D-M, Chen R-W, Chalecka-Franaszek E, Ren M, Hashimoto R, Senatorov V, et al. Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disord 2002; 4: 129–136
- Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK. Pharmacological increase in human brain gray matter. In. Detroit; 2000.
- Moore GJ, Bebchuk JM, Hasanat K, Chen G, Seraji-Bozorgzad N, Wilds IB, et al. Lithium increases N–acetyl-aspartate in the human brain: in vivo evidence in support of bcl's neurotrophic effects?. Biol Psychiatry 2000; 48: 1–8
- Bai O, Zhang H, Li XM. Antipsychotic drugs clozapine and olanzapine upregulate bcl-2 mRNA and protein in rat frontal cortex and hippocampus. Brain Res 2004; 1010: 81–86
- Okamura N, Hashimoto K, Kanahara N, Shimizu E, Kumakiri C, Komatsu N, et al. Protective effect of the antipsychotic drug zotepine on dizocilpine-induced neuropathological changes in rat retrosplenial cortex. Eur J Pharmacol 2003; 461: 93–98
- Turner BJ, Rembach A, Spark R, Lopes EC, Cheema SS. Opposing effects of low and high-dose clozapine on survival of transgenic amyotrophic lateral sclerosis mice. J Neurosci Res 2003; 74: 605–613
- Qing H, Xu H, Wei Z, Gibson K, Li XM. The ability of atypical antipsychotic drugs vs. haloperidol to protect PC12 cells against MPP + -induced apoptosis. Eur J Neurosci 2003; 17: 1563–1570
- Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, et al. Requirements of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003; 301: 805–809
- Angst J, Preisig M. Course of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985. Schweiz Arch Neurol Psychiatr 1995; 146(1)5–16
- Endicott J, Spitzer R, Fleiss J, Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976; 33: 766–771
- Angst J, Angst F, Gerber-Werder R, Gamma A. Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years' follow-up. Arch Suicide Res 2005; 9: 279–300
- Dunn N, Holmes C, Mullee M. Does lithium therapy protect against the onset of dementia?. Alzheimer Dis Assoc Disord 2005; 19: 20–2
- Baldwin JA. Schizophrenia and physical disease: A preliminary analysis of the data from the Oxford Record Linkage Study. Biochemistry of schizophenia and addiction. In search of a common factor, G. Hemmings. MTP Press, Lancaster 1980
- Ösby U, Brandt L, Correia N, Ekbom A, Sparén P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001; 58: 844–50